Michael S Khodadoust

18PUBLICATIONS
86CO-AUTHORS
Molecular targetsMedical biotechnology diagnostics (incl. biosensors)Haematological tumoursMedical molecular engineering of nucleic acids and proteinsAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Aug 25, 2026
Phase 1 Trial with Soquelitinib, a Selective ITK Inhibitor for Treatment of Relapsed/Refractory T Cell Lymphomas.

|Aug 11, 2026
Personalized Circulating Tumor DNA Profiling Enables Superior and Universal Residual Disease Detection in Acute Myeloid Leukemia.

|Jun 18, 2026
A practical approach to risk stratification of incidental T-cell clonality.

|Feb 12, 2026
Personalized Circulating Tumor DNA (ctDNA) Profiling Enables Superior and Universal Measurable Residual Disease (MRD) Detection in Acute Myeloid Leukemia (AML).

Ruwan Gunaratne, Crystal Zhou, Sanjeeth Rajaram

|Nov 25, 2025
Long-term follow-up of gastrointestinal CAR T-cell lymphoma: homing, clonal expansion, and response to cyclosporine.

Hitomi Hosoya, Armando N Bastidas Torres, Sebastian Fernandez-Pol

|Feb 08, 2025
Results from an open-label phase 2a study of cerdulatinib, a dual spleen tyrosine kinase/janus kinase inhibitor, in relapsed/refractory peripheral T-cell lymphoma.

Steven M Horwitz, Tatyana A Feldman, Jing Christine Ye

Pageof 3

Frequent Collaborators

6 joint publications

David M Kurtz

6 joint publications

Youn H Kim

4 joint publications

Ash A Alizadeh

4 joint publications

Sebastian Fernandez-Pol